Clinicopathological and prognostic significance of stromal p16 and p53 expression in oral squamous cell carcinoma

  • 0Division of Tumor Pathology, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke, Tochigi, Japan; Department of Pathology, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke, Tochigi, Japan.

|

|

Summary

This summary is machine-generated.

Stromal p16 and p53 positivity in oral squamous cell carcinoma (OSCC) correlate with aggressive features and poor prognosis. These biomarkers may regulate tumor aggressiveness, offering potential prognostic insights for OSCC patients.

Area Of Science

  • Oncology
  • Cancer Biology
  • Pathology

Background

  • The tumor microenvironment is complex, comprising neoplastic and stromal cells.
  • The roles of p16 and p53 in oral squamous cell carcinoma (OSCC) stroma are not well understood.
  • Understanding stromal markers is crucial for predicting OSCC progression.

Purpose Of The Study

  • To investigate the expression and prognostic significance of p16 and p53 in the stromal cells of OSCC.
  • To determine the association of stromal p16 and p53 with clinicopathological features and patient outcomes.

Main Methods

  • Immunohistochemical analysis of p16 and p53 expression in 116 OSCC tissue samples.
  • Correlation of protein expression with histological grade, invasion patterns, and patient survival.
  • Multivariate analysis to identify independent prognostic factors.

Main Results

  • p16-positive stromal cells were found in 74 samples; p53-positive stromal cells in 33 samples.
  • Both p16 and p53 positivity were linked to higher histological grade, lymphovascular invasion, immature stroma, and infiltrative patterns.
  • Stromal p16 and p53 positivity were independent predictors of poor overall survival.

Conclusions

  • Stromal p16 and p53 expression are associated with aggressive OSCC phenotypes.
  • These markers serve as independent prognostic factors for overall survival in OSCC patients.
  • Stromal p16 and p53 positivity may play a regulatory role in OSCC tumor aggressiveness.